| KOTAK MANUFACTURE IN INDIA FUND
An open ended equity scheme following manufacturing theme
| KOTAK MANUFACTURE IN INDIA FUND
An open ended equity scheme following manufacturing theme

      

      
Investment Objective

The scheme shall seek to generate capital appreciation by investing in a diversified portfolio of companies that follow the manufacturing theme. However, there is no assurance that the objective of the Scheme will be realized.

The scheme shall seek to generate capital appreciation by investing in a diversified portfolio of companies that follow the manufacturing theme. However, there is no assurance that the objective of the Scheme will be realized.

Issuer/Instrument Industry/
Rating
% to Net
Assets

Equity & Equity related
Pharmaceuticals and Biotechnology 15.76
Sun Pharmaceuticals Industries Ltd. 5.26
Dr Reddys Laboratories Ltd. 4.10
Cipla Ltd. 2.84
Zydus Lifesciences Limited 2.50
GLAND PHARMA LIMITED 1.06
Automobiles 15.00
Mahindra & Mahindra Ltd. 5.63
Maruti Suzuki India Limited 5.51
Eicher Motors Ltd. 2.31
Tata Motors Ltd. 1.55
Industrial Products 10.36
Carborundum Universal Ltd. 2.62
Bharat Forge Ltd. 2.53
AIA Engineering Limited. 2.03
Cummins India Ltd. 1.78
Supreme Industries Limited 1.40
Consumer Durables 9.25
V-Guard Industries Ltd. 1.76
Bata India Ltd. 1.57
Whirlpool of India Ltd. 1.50
Kajaria Ceramics Ltd. 1.45
Voltas Ltd. 0.95
Dixon Technologies India Ltd. 0.71
Elin Electronics Ltd. 0.71
Amber Enterprises India Ltd. 0.60
Auto Components 7.86
Bosch Ltd. 2.20
Samvardhana Motherson International Limited 1.41
Balkrishna Industries Ltd. 1.29
Schaeffler India Ltd 1.14
Apollo Tyres Ltd. 0.93
Sona BLW Precision Forgings Ltd 0.89
Petroleum Products 7.21
RELIANCE INDUSTRIES LTD. 5.40
Bharat Petroleum Corporation Ltd. 1.81
Non - Ferrous Metals 4.10
Hindalco Industries Ltd 4.10
Fertilizers and Agrochemicals 3.65
P I Industries Ltd 1.90
Coromandel International Ltd. 1.75
Electrical Equipment 3.57
ABB India Ltd 2.25
Thermax Ltd. 1.32
Chemicals and Petrochemicals 3.46
SRF Ltd. 1.38
Solar Industries India Limited 1.05
Tata Chemicals Ltd 1.03
Construction 3.36
Larsen And Toubro Ltd. 3.36
Ferrous Metals 3.01
Tata Steel Ltd. 3.01
Cement and Cement Products 2.80
Ultratech Cement Ltd. 2.80
Aerospace and Defense 1.83
Bharat Electronics Ltd. 1.83
Personal Products 1.69
Godrej Consumer Products Ltd. 1.69
Beverages 1.64
United Breweries Ltd. 1.64
Agricultural, Commercial and Constr 1.58
Ashok Leyland Ltd. 1.58
Diversified 1.35
3M India Ltd. 1.35
Textiles and Apparels 1.00
Garware Technical Fibres Ltd. 1.00
Equity & Equity related - Total 98.48
Triparty Repo 2.86
Net Current Assets/(Liabilities) -1.34
Grand Total 100.00



NAV
Reg-Plan-IDCWRs11.061
Dir-Plan-IDCWRs11.060
Growth optionRs11.245
Direct Growth optionRs11.245

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Growth and Income Distribution cum capital withdrawal (IDCW) (Payout and Reinvestment)


Fund Manager* Mr.Harish Krishnan Mr. Abhishek Bisen
Benchmark Nifty India Manufacturing Index TRI
Allotment dateFebruary 22, 2022
AAUMRs936.81 crs
AUMRs948.43 crs
Folio count45,425

IDCW Frequency

Trustee's Discretion


Ratios
Portfolio Turnover2.26%

Minimum Investment Amount

Initial Investment: Rs5000 and in multiple ofRs1 for purchase and of Rs0.01 for switches
Additional Investment: Rs1000 & in multiples of Rs1 for purchase and for Rs0.01 for switches

Ideal Investments Horizon: 5 years & above


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load: a)For redemption / switch out of upto 10% of the initial investment amount (limit) purchased or switched in within 1 year from the date of allotment: Nil.
b)If units redeemed or switched out are excess of the limit within 1 year from the date of allotment: 1%
c)If units are redeemed or switched out or after 1 year from the date of allotment: NIL
Units issued on reinvestment of IDCW shall not be subject to entry and exit load.


Total Expense Ratio**

Regular: 2.27%; Direct: 0.57%


Data as on January 31, 2023

Fund


Benchmark
This product is suitable for investors who are seeking*:
  • Long-term capital growth
  • Investment equity and equity related securities across market capitalisation.

* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

The above risk-o—meter is based on the scheme portfolio as on 31st January 2023. An addendum may be issued or updated on the website for new riskometer


**Total Expense Ratio includes applicable B30 fee and GST.
* For Fund Manager experience, please refer 'Our Fund Managers'
For scheme performance, please refer 'Scheme Performances'